| __timestamp | BioMarin Pharmaceutical Inc. | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 621276000 | 1699214000 |
| Thursday, January 1, 2015 | 737887000 | 1930998000 |
| Friday, January 1, 2016 | 907234000 | 1912291000 |
| Sunday, January 1, 2017 | 1071860000 | 2152011000 |
| Monday, January 1, 2018 | 1175948000 | 2049560000 |
| Tuesday, January 1, 2019 | 1344582000 | 2341232000 |
| Wednesday, January 1, 2020 | 1336183000 | 2255165000 |
| Friday, January 1, 2021 | 1375760000 | 1962596000 |
| Saturday, January 1, 2022 | 1612370000 | 2231530000 |
| Sunday, January 1, 2023 | 1842161000 | 2322701000 |
| Monday, January 1, 2024 | 2273680000 |
Unlocking the unknown
In the competitive landscape of the pharmaceutical industry, understanding financial performance is crucial. This analysis compares the gross profit trends of BioMarin Pharmaceutical Inc. and Grifols, S.A. from 2014 to 2023. Over this period, Grifols consistently outperformed BioMarin, with an average gross profit approximately 73% higher. Notably, Grifols peaked in 2019, achieving a gross profit of over 2.34 billion, while BioMarin reached its highest in 2023 with 1.84 billion. Despite BioMarin's steady growth, Grifols maintained a robust lead, reflecting its strong market position. The data highlights the importance of strategic financial management in sustaining competitive advantage. As the industry evolves, these insights offer valuable lessons for stakeholders aiming to navigate the complexities of pharmaceutical economics.
Key Insights on Gross Profit: Sanofi vs BioMarin Pharmaceutical Inc.
Who Generates Higher Gross Profit? Gilead Sciences, Inc. or BioMarin Pharmaceutical Inc.
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Genmab A/S and BioMarin Pharmaceutical Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Viatris Inc. and Grifols, S.A. Trends
Key Insights on Gross Profit: Bio-Techne Corporation vs BioMarin Pharmaceutical Inc.
Key Insights on Gross Profit: BioMarin Pharmaceutical Inc. vs Corcept Therapeutics Incorporated
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Grifols, S.A.
Gross Profit Analysis: Comparing BioMarin Pharmaceutical Inc. and Bausch Health Companies Inc.
BioMarin Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Grifols, S.A. vs Ligand Pharmaceuticals Incorporated
Gross Profit Comparison: Grifols, S.A. and Travere Therapeutics, Inc. Trends